ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA approves IMBRUVICA® (ibrutinib) for treatment of chronic lymphocytic leukaemia and small lymphocytic lymphoma
April 23, 2020IMBRUVICA (ibrutinib), in combination with rituximab, has been given approval in the US for the treatment of chronic lymphocytic leukaemia and small lymphocytic lymphoma. -
US clears Verastem’s Copiktra for blood cancers
September 27, 2018Verastem Oncology’s Copiktra has been approved in the US for the treatment relapsed or refractory chronic lymphocytic leukaemia/small... -
US nod for Venclexta/Rituxan combo
July 10, 2018US regulators have approved a combination of AbbVie and Roche’s Venclexta in combination with Roche/Biogen's Rituxan (rituximab) to treat chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL).
Pharma Sources Insight January 2025
